Quaker Houghton · NYSE:KWR
Quaker Houghton — Q2 2026 Earnings Presentation
15 slides from Quaker Houghton's earnings presentation, Jul 31, 2026
Slide 1: Second Quarter 2026 Results Investor Conference Call
Quaker Houghton Second Quarter 2026 Results Investor Conference Call
Slide 2: Forward-Looking Statements
Forward-Looking Statements Forward-Looking Statements This presentation contains “forward-looking statements” that fall under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and the Securities Act of 1933, as amended. These statements can be identified by the fact
Slide 3: Non-GAAP Measures
Non-GAAP Measures The information in this presentation includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP gross profit, non-GAAP gross margin, taxes on income before equity
Slide 4: Speakers
Speakers Joe Berquist Chief Executive Officer, President Tom Coler Executive Vice President, Chief Financial Officer Robert T. Traub Senior Vice President, General Counsel & Corporate Secretary John Dalhoff Director, Investor Relations 4 ©2026 Quaker Houghton. All Rights Reserved
Slide 5: Q2'26 Highlights
Q2’26 Highlights Q2’26 YTD 2026 $533m $85m $1,013m $158m Net Sales Adjusted EBITDA1 Net Sales Adjusted EBITDA1 $2.19 $29m $3.82 $33m Non-GAAP Operating Non-GAAP Operating Earnings per Cash Flow Earnings per Cash Flow Diluted Share1 Diluted Share1 $24m 2.3x Share Leverage Ratio1,2 Repurchases 1 This
Slide 6: Financial Snapshot
Financial Snapshot (Unaudited; Dollars in millions, unless otherwise noted) Q2 2026 Q2 2025 Variance(1) YTD 2026 YTD 2025 Variance(1) GAAP Net sales $ 532.6 $ 483.4 $ 49.2 10.2% $1,013.0 $ 926.3 $ 86.7 9.4% Gross profit 189.2 171.7 17.5 10.2% 365.9 333.0 33.0 9.9% Gross margin (%) 35.5% 35.5% —% 36.
Slide 7: Total Company Volume Trend
Total Company Volume Trend1 (kilograms) Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Sales volumes increased by 7% in Q2’26 compared to Q2’25, primarily due to new business wins across all segments. Sequentially, sales volumes increased by 7% in Q2’26 compared to Q
Slide 8: Adjusted EBITDA
Adjusted EBITDA1 (dollars in millions) $320 $85 $311 $312 $299 $75 $257 2 2022 2023 2024 2025 Q2'26 LTM Q2 2025 Q2 2026 Generated $85m of adjusted EBITDA in Q2’26, an increase of 13% year-over-year 1 This is a non-GAAP measure, refer to the reconciliations of our non-GAAP measures to their most comp
Slide 9: Leverage and Liquidity Update
Leverage and Liquidity Update Net Debt and Leverage Ratio1 • Total debt of $876 million (Dollars in Millions) • Cash and cash equivalents of $155 million $787 $815 $774 • Net debt of $721 million $765 $753 $735 $696 $703 $691 $705 $721 • Leverage of 2.3x as of June 30, 20261 $628 $561 $574 $549 • Op
Slide 10: Appendix: Actual and Non-GAAP Results
Appendix Actual and Non-GAAP Results
Slide 11: Non-GAAP Gross Profit and Operating Income Reconciliation
Non-GAAP Gross Profit and Operating Income Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) Three Months Ended Six Months Ended June 30, June 30, Non-GAAP Gross Profit and Margin Reconciliations 2026 2025 2026 2025 Gross profit $ 189,204 $ 171,723 $ 365,939 $ 332,983 Acquisit
Slide 12: Adjusted EBITDA Reconciliation
Adjusted EBITDA Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) Three Months Ended Six Months Ended June 30, June 30, EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin Reconciliations: 2026 2025 2026 2025 Net income attributable to Quaker Chemical Corporation $ 26,835 $ (66,58
Slide 13: Adjusted EBITDA Reconciliation
Adjusted EBITDA Reconciliation (Unaudited; Dollars in thousands, unless otherwise noted) Twelve Months Ended December 31, EBITDA, Adjusted EBITDA, and Adjusted EBITDA Margin Reconciliations: 2025 2024 2023 2022 Net income attributable to Quaker Chemical Corporation $ (2,488) $ 116,644 $ 112,748 $ (1
Slide 14: Non-GAAP EPS Reconciliation
Non-GAAP EPS Reconciliation Three Months Ended Six Months Ended June 30, June 30, Non-GAAP Earnings per Diluted Share Reconciliations 2026 2025 2026 2025 GAAP earnings (loss) per diluted share attributable to Quaker Chemical Corporation common shareholders $ 1.55 $ (3.78) $ 2.68 $ (3.04) Equity inco
Slide 15: Segment Performance
Segment Performance (Unaudited; Dollars in thousands, except per share amounts) Three Months Ended Six Months Ended June 30, June 30, 2026 2025 2026 2025 Net sales Americas $ 236,513 $ 221,062 $ 450,241 $ 434,773 EMEA 158,436 139,923 300,519 269,201 Asia/Pacific 137,601 122,415 262,269 222,340 Total